Details

Autor(en) / Beteiligte

• Kothandaraman, Narasimhan
• Rengaraj, Anantharaj
• Xue, Bo
• Yew, Wen Shan
• Velan, S Sendhil
• Karnani, Neerja
• Leow, Melvin Khee Shing

Titel

COVID-19 endocrinopathy with hindsight from SARS

Ist Teil von

• American journal of physiology: endocrinology and metabolism, 2021-01, Vol.320 (1), p.E139-E150

Ort / Verlag

United States: American Physiological Society

Erscheinungsjahr

2021

Quelle

MEDLINE

Beschreibungen/Notizen

• The current COVID-19 pandemic is probably the worst the world has ever faced since the start of the new millennium. Although the respiratory system is the most prominent target of SARS-CoV-2 (the contagion of COVID-19), extrapulmonary involvement are emerging as important contributors of its morbidity and lethality. This article summarizes the impact of SARS-CoV and SARS-CoV-2 on the endocrine system to facilitate our understanding of the nature of coronavirus-associated endocrinopathy. Although new data are rapidly accumulating on this novel infection, many of the endocrine manifestations of COVID-19 remain incompletely elucidated. We, hereby, summarize various endocrine dysfunctions including coronavirus-induced new onset diabetes mellitus, hypocortisolism, thyroid hormone, and reproductive system aberrations so that clinicians armed with such insights can potentially benefit patients with COVID-19 at the bedside.